NHS GGC awarded funding to trial My Clinical Outcomes
5th July 2019
NHS Greater Glasgow & Clyde, with funding from the Cancer Innovation Challenge, is working with My Clinical Outcomes to improve the care of ovarian cancer patients through better collection of patient reported outcome & experience measures.
Ovarian cancer is the sixth most commonly diagnosed malignancy in Scottish women. The West of Scotland is an area with one of the highest number of patients with gynaecological cancer across the United Kingdom, with approximately 800 new cases per year. Ovarian cancer patients represent more than a quarter of these patients, with approximately 225 cases per year.
The West of Scotland Cancer Network has actively engaged with the Cancer Experience panel to increase involvement and engagement with patients. The network supports the active collection and review of patient reported outcome and experience measures. Our trial extends these activities and meets the aims of the national Transforming Care After Treatment (TCAT) programme.
My Clinical Outcomes (MCO) offer a web-based platform that automates the collection and analysis of Patient Reported Outcome Measures (PROMs). Using the platform, data is collected regularly and remotely; from diagnosis to treatment and throughout long-term follow-up.
NHS Greater Glasgow and Clyde will work with My Clinical Outcomes to extend the capabilities of the platform to the collection of PROMs specific to ovarian cancer.
The data collected through My Clinical Outcomes will help clinical teams to understand the impact of treatment on an individual’s day to day life. By understanding that impact, the individual and their clinical team can work together to address their needs. Clinical teams will also be better able to predict how people will react to clinical treatments in the longer-term and ultimately improve the quality of life for women affected by ovarian cancer